Genedata Expands Affymetrix GeneChip-CompatibleTM Status For Exon Expression On GeneChip(R) Microarray Platform

Genedata, a leading provider of in silico solutions for the pharmaceutical and life sciences industries, announced that its Expressionist platform has expanded GeneChip-compatible(TM) status for Exon expression with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip(R) microarray platform. Genedata Expressionist® is a modular enterprise system for biomarker discovery.

More: continued here

Filed under: Pharma Industry on March 15th, 2008